Salt Clinical Team
Aligned with the SALT mission of simplifying healthcare, we strive to compile a team of powerful minds behind the ever growing science of hormone therapy, peptides, and health.
Adrienne
Adrienne is our esteemed Clinical Lead at SaltMD, bringing a wealth of experience and expertise to our team. With over 30 years in nursing, Adrienne has held pivotal roles in both clinical and educational settings. She spent 12 years as an instructor in the Departments of Nursing at North Carolina Central University and Campbell University School of Nursing, and her extensive background encompasses high-risk obstetrical management, gynecological surgeries, postpartum and nursery care, as well as IV therapy, peptide treatments, and hormone replacement for both men and women.
A dedicated Nurse Practitioner, Adrienne continually enhances her knowledge by attending workshops and conferences to stay at the forefront of healthcare practices. As a certified personal trainer and nutritional consultant, she actively promotes overall health and wellness in the community. A lifelong learner with a BSN from Emory University and an MSN from Georgia State University, Adrienne embodies the principles of holistic well-being, leadership, and service, making her an invaluable part of SaltMD.
Scientific Advisory Board
At SALT, we believe that science should lead the way in longevity, anti-aging, and biological optimization. That’s why we’ve assembled a world-class Scientific Advisory Board (SAB)—a team of leading experts in longevity and cutting-edge wellness research.
Szilard Voros, MD, FACC, FAHA
Dr. Szilard Voros is a globally recognized physician, cardiologist, geneticist, and serial entrepreneur known for his groundbreaking contributions to precision medicine, cardiovascular research, and biotechnology. His career has been defined by innovation in medical technology, genomics, and drug development, with a focus on advancing preventive healthcare, life extension, and personalized medicine. His work has helped bridge the gap between early disease detection and intervention, improving patient outcomes and redefining approaches to health optimization.
In 2012, Dr. Voros co-founded Global Genomics Group (G3), a precision-medicine-based biotechnology company dedicated to developing novel drugs, nutraceuticals, and blood-based biomarkers. Under his leadership, G3 has pioneered advancements in multi-omics analysis—integrating genomics, proteomics, metabolomics, and digital health technologies—to enhance preventive care and longevity. His expertise in cardiovascular imaging and biomarker discovery has shaped the way clinicians diagnose and manage heart disease, metabolic disorders, and age-related conditions.
A Fellow of both the American College of Cardiology (FACC) and the American Heart Association (FAHA), Dr. Voros is deeply involved in clinical research, scientific leadership, and medical entrepreneurship. His extensive knowledge in pharmaceutical development, longevity science, and digital health has positioned him as a thought leader in precision wellness and biological optimization. Through his ongoing work, he continues to drive advancements in diagnostics, targeted therapies, and personalized health strategies, ultimately helping individuals achieve longer, healthier lives.
Gustavo Vazquez, MD
